The Center for Neurodegeneration and Experimental Therapeutics (CNET) is devoted to finding therapies for neurodegenerative diseases, including Alzheimer’s disease and related dementias, Parkinson’s disease, Huntington’s disease, and ALS.  CNET’s core goals are to promote the discovery of novel treatments for neurodegenerative disorders through basic and translational research, to teach scientists and clinicians about these diseases, and to facilitate the application of these discoveries to clinical care of patients.